Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them
Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them
复制标题
DOI：
10.1007/s11920-011-0222-2
复制
发表时间：
2011-10-01
影响因子：
6.7
通讯作者：
Harris, Alex H. S.
中科院分区：
文献类型：
--
作者：
Oliva, Elizabeth M.;Maisel, Natalya C.;Harris, Alex H. S.
物质使用障碍是一种非常普遍的、使人衰弱的疾病，有广泛的证据基础可以有效地治疗这种疾病，但治疗成瘾障碍的药物疗法却没有得到充分利用。这篇综述的目的是描述在系统、提供者和患者层面上可能导致酒精和阿片依赖药物疗法采用和利用不佳的障碍，并讨论克服这些障碍的方法。可能需要在所有三个层面进行多方面的努力，以加快药物治疗的采用。需要更多的研究来帮助我们从患者的角度更好地理解障碍。促进药物治疗成瘾障碍的策略应该加以修改，以适应实践、系统和患者个体的需要。药物治疗是成瘾治疗临床手段中的宝贵工具；因此，克服实施障碍可能会改善临床和社会结果。
Substance use disorders are highly prevalent, debilitating conditions for which effective pharmacotherapies exist with a broad evidence base, yet pharmacotherapy for the treatment of addiction disorders is underutilized. The goals of this review are to describe the barriers that may contribute to poor adoption and utilization of pharmacotherapy for alcohol and opioid dependence at the system, provider, and patient level and to discuss ways to overcome those barriers. Multifaceted efforts directed at all three levels may be needed to speed pharmacotherapy adoption. More research is needed to help us better understand barriers from patients' perspectives. Strategies to promote adoption of pharmacotherapy for addiction disorders should be modified to fit the needs of the practice, system, and individual patients. Pharmacotherapy is a valuable tool in the clinical armamentarium of addiction treatment; thus, overcoming barriers to implementation may improve clinical and social outcomes.